WeVote

Bill

Bill

S 1190

Lung Cancer Awareness Month

2025-2026 Regular Session Introduced by Brian Adams and 44 co-sponsors

Declares November 2026 as Lung Cancer Awareness Month to raise statewide awareness, promote screening and biomarker testing, and encourage public health messaging.

Introduced, adopted, returned with concurrence
0
WeVote Research Nonpartisan
Bill Summary · S 1190

Summary of Bill S 1190 (Session 2025-2026) – South Carolina

Purpose and Intent

  • This is a concurrent resolution by both chambers declaring November 2026 as “Lung Cancer Awareness Month” in South Carolina.
  • The resolution emphasizes the impact of lung cancer in the state and promotes awareness, screening, and biomarker testing as means to reduce mortality.

Key Provisions

  • Proclaims November 2026 as Lung Cancer Awareness Month in South Carolina.
  • Directs that a copy of the resolution be presented to the Governor for acknowledgment and action.

Who/What Will Be Affected

  • The declaration applies statewide to all residents of South Carolina.
  • While primarily symbolic, the resolution targets public awareness and may influence public health messaging and education initiatives during the designated month.

Procedural and Timeline Aspects

  • Introduced and adopted in the Senate on May 12, 2026, and sent to the House for consideration.
  • The resolution requires concurrence by both the Senate and House (a shared, non-binding legislative action).
  • If enacted, Governor’s acknowledgment is anticipated via formal presentation of the resolution.

Context and Rationale (As Stated in the Bill)

  • Lung cancer is presented as a leading cancer diagnosed in South Carolina, with incidence and mortality rates higher than national averages.
  • The bill notes that a substantial portion of new cases arise in individuals who have never smoked or who quit, pointing to non-smoker risk factors such as radon, secondhand smoke, asbestos, environmental exposures, and genetic factors.
  • It asserts that increasing public awareness, expanding access to screening, and improving biomarker testing could meaningfully reduce mortality.

Notable Details

  • The resolution cites specific public health concerns: higher local lung cancer incidence and mortality relative to national figures, and the potential benefits of screening and biomarker testing.
  • A broad slate of Senate sponsors and co-sponsors is listed, indicating cross-chamber and cross-party support for the proclamation.

Practical Impact

  • The immediate effect is ceremonial and educational, raising awareness about lung cancer during November 2026.
  • May influence state health agencies, healthcare providers, and public communications to emphasize lung cancer risk factors, early detection, and prevention strategies during the designated month.

If you’d like, I can provide a concise one-paragraph summary for quick briefing or a side-by-side comparison with similar prior proclamations.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.